⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for antitumor immunity

Every month we try and update this database with for antitumor immunity cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic CancerNCT02311361
Pancreatic Neop...
Pancreatic Canc...
Cancer of Pancr...
Cancer of the P...
Pancreas Cancer
Durvalumab
Tremelimumab
Sterostatic bod...
18 Years - 99 YearsNational Institutes of Health Clinical Center (CC)
VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC)NCT04166383
Metastatic Colo...
Colorectal Neop...
Colorectal Carc...
Colorectal Canc...
Colorectal Tumo...
Vascular Biogen...
Nivolumab
18 Years - National Institutes of Health Clinical Center (CC)
Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic CancerNCT02311361
Pancreatic Neop...
Pancreatic Canc...
Cancer of Pancr...
Cancer of the P...
Pancreas Cancer
Durvalumab
Tremelimumab
Sterostatic bod...
18 Years - 99 YearsNational Institutes of Health Clinical Center (CC)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: